The value of volumetric breast density to help improve breast cancer risk prediction models and monitor clinical treatment was the focus of numerous abstracts presented at the 2014 San Antonio Breast Cancer Symposium (SABCS).
The value of volumetric breast imaging data to provide critical insight for optimal breast imaging quality and workflow was the focus of numerous abstracts accepted for presentation at the 100th Annual Meeting of the Radiology Society of North America (RSNA), November 30-December 5, 2014.
Viztek announced upgraded features that have been added to its Exa PACS.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Less than 30 days after the Sapheneia Scannerside partnership announcement, the two companies released CMS Lung Screening, ClearCT Lung.
IDS debuted at RSNA 2014 AbbaDox CRM version 2.0 with advanced architecture, enhanced database design, intuitive graphical interface, geographic mapping functionality, analytics and a marketing toolset.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Blackford Analysis announced a technology partnership with Viztek.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Two-thirds of women treated for early-stage breast cancer in the United States receive longer radiation therapy than necessary, according to a new study published in the Journal of the American Medical Association (JAMA) from Penn Medicine researchers Ezekiel J. Emanuel, M.D., Ph.D., and Justin E. Bekelman, M.D.
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients less than 2 years of age, including term neonates, to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system.
TiaLinx Inc. announced the launch of its new product line, the AR60-A.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
IDS debuted at RSNA 2014 Voice2Dox speech recognition and reporting platform with cloud-based clinical speech recognition by Nuance.
Lexmark International announced the acquisition of Toronto-based Claron Technology, a provider of medical image viewing, distribution, sharing and collaboration software technology.
Ampronix announced a new addition to its video converter family – Scanmaxx Laplinx.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
CoActiv Medical debuted a fully cloud-based version of its advanced Exam-RIS (radiology information system) solution at the Radiological Society of North America (RSNA) 2014 conference as part of its full suite of digital radiology products. Along with this the vendor introduced a diagnostic version of Exam-Browser, which enables anywhere, anytime high-fidelity reading capabilities on any high-resolution display.
Merge Healthcare Inc. announced the launch of its Merge One solution at the Radiology Society of North America annual conference in Chicago Nov. 30-Dec. 5. Merge One brings ambulatory radiology sites the ability to power their entire business in a cloud-based environment.
Zelina Amir was the 1,000th patient to complete treatment at the ProCure Proton Therapy Center in Somerset, New Jersey.
A substantial percentage of patients who receive radiologist recommendations for chest computed tomography (CT) to evaluate abnormal findings on outpatient chest X-rays have clinically relevant findings, including cancer, according to a new study published online in the journal Radiology.
Philips introduced the IntelliSpace Portal 7.0 at RSNA 2014.
Ampronix announced the availability of its new DVMAXX HD medical grade high-definition (HD) video recorder and image capture device.
Noninvasive brain scans, such as functional magnetic resonance imaging (fMRI), have led to basic science discoveries about the human brain, but they've had only limited impacts on people's day-to-day lives. A review article published in the Jan. 7 issue of the Cell Press journal Neuron, however, highlights a number of recent studies showing that brain imaging can help predict an individual's future learning, criminality, health-related behaviors and response to drug or behavioral treatments. The technology may offer opportunities to personalize educational and clinical practices.
A clinical trial that combined stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.